Hosted on MSN

Biogen’s Zurzuvae approved as first postpartum depression drug in Europe

Millions of parents in Europe who suffer from postpartum depression will now have access to a pharmaceutical treatment, following the European Commission (EC)’s approval of Biogen’s Zurzuvae ...
BMJ

Depression, reduced physical activity and the risk of heart disease: a prospective cohort of European middle-aged and older adults

5 Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Providencia, Chile 6 Universidad de Santiago de Chile (USACH), Escuela de Ciencias de la Actividad Física, el Deporte y la Salud, ...
News Medical

European research project seeks faster depression treatment solutions

Depression can affect anyone. It is common, and in many cases severe. These days, there are good treatments available, typically involving a combination of psychotherapy and medication. However, ...
Nasdaq

Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe

CAMBRIDGE, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced that the European Commission (EC) has granted marketing authorization for ZURZUVAE® (zuranolone) to treat post ...
AOL

Facts about the Great Depression that put modern struggles into perspective

While modern economic downturns and crises, such as the 2008 financial crisis or recent inflation, have been challenging and created genuine hardship for millions of families, the sheer scale and ...